Suppr超能文献

强迫症患者的 5-羟色胺 2A 受体:[11C]MDL 100907 的正电子发射断层扫描研究。

Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907.

机构信息

Department of Psychiatry, Columbia University, College of Physicians and Surgeons, New York, New York 10032, USA.

出版信息

Biol Psychiatry. 2011 Nov 1;70(9):897-904. doi: 10.1016/j.biopsych.2011.06.023.

Abstract

BACKGROUND

Serotonergic abnormalities are hypothesized to contribute to obsessive-compulsive disorder (OCD). This study used positron emission tomography with the radioligand [11C]MDL 100907 to examine whether the distribution of serotonin 2A (5-HT(2A)) receptors is altered in OCD.

METHODS

Nineteen OCD subjects, free of psychiatric medications and depression, and 19 matched healthy subjects underwent positron emission tomography scans following injection of [11C]MDL 100907. Total distribution volumes were derived by kinetic analysis using the arterial input function. Two measures of 5-HT(2A) availability were computed: the ratio at equilibrium of specifically bound radiotracer either to nondisplaceable radiotracer in tissue (BP(ND)) or to unmetabolized tracer in arterial plasma (BP(p)). Groups were compared using a region of interest (ROI) analysis and voxelwise analysis of spatially normalized parametric maps. ROIs included cortical (orbitofrontal, dorsolateral prefrontal, medial prefrontal, anterior cingulate, temporal, parietal, occipital, and insular cortex) and limbic (entorhinal cortex, parahippocampal gyrus, and medial temporal lobe) regions.

RESULTS

No significant group differences were observed in [11C]MDL 100907 BP(ND) or BP(p) in the ROIs or in the voxelwise analysis of BP(ND) maps. There was a significant correlation in the orbitofrontal cortex between [11C]MDL 100907 binding and age of onset, with earlier age of onset associated with higher binding.

CONCLUSIONS

Adults with OCD are not characterized as a group by major changes in 5-HT(2A) availability in cortical or limbic brain regions. Further research is warranted to examine potential differences in 5-HT(2A) availability between early- and late-onset OCD and to assess 5-HT(2A) function in relation to other neurotransmitter systems implicated in OCD.

摘要

背景

血清素能异常被假设与强迫症(OCD)有关。本研究使用正电子发射断层扫描技术,用放射性配体[11C]MDL 100907,研究 5-羟色胺 2A(5-HT2A)受体的分布是否在 OCD 中发生改变。

方法

19 名未服用精神药物和抑郁症的 OCD 患者和 19 名匹配的健康受试者在注射[11C]MDL 100907 后进行正电子发射断层扫描。通过使用动脉输入函数的动力学分析得出总分布体积。计算了 5-HT2A 可用性的两个指标:组织中特异性结合放射性示踪剂与不可置换放射性示踪剂(BP(ND))或动脉血浆中未代谢示踪剂(BP(p))的平衡时比值。使用感兴趣区(ROI)分析和空间归一化参数图的体素分析比较两组。ROI 包括皮质(眶额、背外侧前额、内侧前额、前扣带、颞叶、顶叶、枕叶和岛叶皮质)和边缘(内嗅皮质、海马旁回和内侧颞叶)区域。

结果

在 ROI 或 BP(ND)图的体素分析中,未观察到[11C]MDL 100907 BP(ND)或 BP(p)在 OCD 组和对照组之间存在显著差异。在眶额皮质中,[11C]MDL 100907 结合与发病年龄之间存在显著相关性,发病年龄较早与结合较高相关。

结论

OCD 成人的皮质或边缘脑区 5-HT2A 可用性无明显变化。需要进一步研究以检查早期和晚期 OCD 之间 5-HT2A 可用性的潜在差异,并评估 5-HT2A 功能与强迫症中涉及的其他神经递质系统的关系。

相似文献

1
Serotonin 2A receptors in obsessive-compulsive disorder: a positron emission tomography study with [11C]MDL 100907.
Biol Psychiatry. 2011 Nov 1;70(9):897-904. doi: 10.1016/j.biopsych.2011.06.023.
2
Serotonin transporters in obsessive-compulsive disorder: a positron emission tomography study with [(11)C]McN 5652.
Biol Psychiatry. 2003 Dec 15;54(12):1414-21. doi: 10.1016/s0006-3223(03)00544-4.
3
In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder.
Neuroimage. 2008 Aug 1;42(1):306-14. doi: 10.1016/j.neuroimage.2008.04.233. Epub 2008 Apr 27.
4
Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.
Neuroimage. 2010 Jan 1;49(1):121-6. doi: 10.1016/j.neuroimage.2009.07.069. Epub 2009 Aug 4.
6
Validation of a tracer kinetic model for the quantification of 5-HT(2A) receptors in human brain with [(11)C]MDL 100,907.
J Cereb Blood Flow Metab. 2007 Jan;27(1):161-72. doi: 10.1038/sj.jcbfm.9600323. Epub 2006 May 10.
8
Patients with obsessive-compulsive disorder have increased 5-HT2A receptor binding in the caudate nuclei.
Int J Neuropsychopharmacol. 2005 Sep;8(3):391-401. doi: 10.1017/S1461145705005055. Epub 2005 Apr 1.
10
Simplified quantification of 5-HT2A receptors in the human brain with [11C]MDL 100,907 PET and non-invasive kinetic analyses.
Neuroimage. 2010 Apr 15;50(3):984-93. doi: 10.1016/j.neuroimage.2010.01.037. Epub 2010 Jan 18.

引用本文的文献

3
Serotonergic underpinnings of obsessive-compulsive disorder: A systematic review and meta-analysis of neuroimaging findings.
Psychiatry Clin Neurosci. 2025 Feb;79(2):48-59. doi: 10.1111/pcn.13760. Epub 2024 Nov 7.
4
Progress in the application of molecular imaging in psychiatric disorders.
Psychoradiology. 2023 Oct 9;3:kkad020. doi: 10.1093/psyrad/kkad020. eCollection 2023.
5
Obsessive-compulsive disorder: Etiology, neuropathology, and cognitive dysfunction.
Brain Behav. 2023 Jun;13(6):e3000. doi: 10.1002/brb3.3000. Epub 2023 May 3.
6
Neurobiological outcomes of cognitive behavioral therapy for obsessive-compulsive disorder: A systematic review.
Front Psychiatry. 2022 Dec 9;13:1063116. doi: 10.3389/fpsyt.2022.1063116. eCollection 2022.
8
Radiotracers for the Central Serotoninergic System.
Pharmaceuticals (Basel). 2022 May 3;15(5):571. doi: 10.3390/ph15050571.
9
Blockade of 5-Hydroxytryptamine 2A Receptor Attenuates Precipitation of Naloxone-Induced Withdrawal Symptoms in Opioid-Exposed Mice.
Front Behav Neurosci. 2022 Feb 9;15:797217. doi: 10.3389/fnbeh.2021.797217. eCollection 2021.
10
Pharmacotherapeutic Strategies and New Targets in OCD.
Curr Top Behav Neurosci. 2021;49:331-384. doi: 10.1007/7854_2020_204.

本文引用的文献

2
Reduced serotonin transporter binding in the insular cortex in patients with obsessive-compulsive disorder: a [11C]DASB PET study.
Neuroimage. 2010 Jan 1;49(1):121-6. doi: 10.1016/j.neuroimage.2009.07.069. Epub 2009 Aug 4.
3
Using individual items to clarify OCD symptom structure: the case for five factors.
Am J Psychiatry. 2009 Jun;166(6):728-9; author reply 729-31. doi: 10.1176/appi.ajp.2009.09020287.
4
Paediatric obsessive-compulsive disorder, a neurodevelopmental disorder? Evidence from neuroimaging.
Neurosci Biobehav Rev. 2009 Jun;33(6):818-30. doi: 10.1016/j.neubiorev.2009.01.003. Epub 2009 Jan 21.
5
Brain imaging in pediatric obsessive-compulsive disorder.
J Am Acad Child Adolesc Psychiatry. 2008 Nov;47(11):1262-72. doi: 10.1097/CHI.0b013e318185d2be.
6
Further development of YBOCS dimensions in the OCD Collaborative Genetics study: symptoms vs. categories.
Psychiatry Res. 2008 Jul 15;160(1):83-93. doi: 10.1016/j.psychres.2007.07.010. Epub 2008 Jun 2.
7
In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder.
Neuroimage. 2008 Aug 1;42(1):306-14. doi: 10.1016/j.neuroimage.2008.04.233. Epub 2008 Apr 27.
8
Dose-occupancy study of striatal and extrastriatal dopamine D2 receptors by aripiprazole in schizophrenia with PET and [18F]fallypride.
Neuropsychopharmacology. 2008 Dec;33(13):3111-25. doi: 10.1038/npp.2008.33. Epub 2008 Apr 16.
9
Consensus nomenclature for in vivo imaging of reversibly binding radioligands.
J Cereb Blood Flow Metab. 2007 Sep;27(9):1533-9. doi: 10.1038/sj.jcbfm.9600493. Epub 2007 May 9.
10
Taboo thoughts and doubt/checking: a refinement of the factor structure for obsessive-compulsive disorder symptoms.
Psychiatry Res. 2007 Jun 30;151(3):255-8. doi: 10.1016/j.psychres.2006.09.005. Epub 2007 Mar 21.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验